Revascularization techniques to treat primary critical limb ischemia (CLI) may be more cost-effective and associated with longer survival than primary major amputation, according to new research published in the Journal of the American Heart Association.

Shorter reperfusion times for patients with ST-segment elevation myocardial infarction (STEMI) are associated with fewer cases of in-hospital heart failure and fewer readmissions for heart failure over the next 30 days, according to an observational study from Singapore published in Circulation: Cardiovascular Quality and Outcomes.

Instantaneous wave-free ratio (iFR) and fractional flow reserve (FFR) were equally safe in deferring patients from coronary revascularization, according to a pooled analysis of two randomized trials published Aug. 6 in JACC: Cardiovascular Interventions.

Patients with chronic kidney disease (CKD) who undergo coronary revascularization experience fewer adverse events in the short term with PCI compared to coronary artery bypass grafting (CABG) but similar three-year risks of death, stroke or heart attack.

Andrew Wolf, MD, a 63-year-old cardiologist, swam the English Channel to raise £20,000, or roughly $26,000, in funds for a 3D bioprinter to be used at the Bristol Children’s Hospital in the U.K.

A new North American consensus statement published July 30 in Circulation recommends a non-vitamin K antagonist oral anticoagulant (NOAC) and the P2Y12 inhibitor clopidogrel for most patients with atrial fibrillation undergoing PCI.

Patients who undergo coronary artery bypass grafting (CABG) have shorter operations, fewer complications and better survival rates if they have surgeons who are subspecialized in CABG, researchers report in The Annals of Thoracic Surgery.

Abbott announced it will conduct a pivotal clinical study in the U.S. of its Tendyne Transcatheter Mitral Valve Replacement (TMVR) system, for the treatment of mitral regurgitation (MR).